Beauty Health (NASDAQ:SKIN) Stock Price Down 1.4% – Here’s What Happened

The Beauty Health Company (NASDAQ:SKIN) dropped 1.4% on Monday . The company traded as low as $1.42 and last traded at $1.44. Approximately 422,635 shares were traded during mid-day trading, a decline of 37% from the average daily volume of 671,696 shares. The stock had previously closed at $1.46.

Beauty Health News Roundup

Here are the key news stories impacting Beauty Health this week:

• Positive Sentiment: Growing preventive skincare adoption in India signals expanding addressable market and earlier lifetime customer engagement, which could support longer-term service and product revenue for companies in the professional-beauty channel. Read More.
• Positive Sentiment: Industry forecasts listing the top beauty trends for 2026 point to sustained consumer interest and innovation (routine upgrades, tech-enabled treatments), a tailwind for companies selling new treatments and clinical devices. Read More.
• Positive Sentiment: Seasonal and barrier-skin concerns (winter damage, modern environmental causes) tend to raise short-term demand for corrective treatments and dermatologist-recommended products, supporting quarterly revenue cadence in cold months. Read More.
• Neutral Sentiment: Broad consumer education pieces on modern-skin causes and beauty resolutions increase awareness but are non-specific on channel — could benefit both pro services and mass-market brands. Read More.
• Neutral Sentiment: Articles highlighting niche ingredients or benefits (espresso skin benefits, mindful skincare resolutions) boost category interest but are unlikely to move a single stock materially on their own. Read More.
• Neutral Sentiment: Influencer-driven pieces (Kardashian/Jenner tips) can amplify demand episodically; useful for marketing but unpredictable for professional channels. Read More.
• Neutral Sentiment: Coverage of DIY risks and cosmetic overuse highlights a double-edged trend: consumer experimentation can cut into professional spend, but reported harm often drives people back to clinicians for corrective treatments. Read More.
• Negative Sentiment: Product-review and “best at-home mask” articles spotlight affordable consumer products (eye masks, collagen masks) that compete with professional services and could pressure spend per customer if at-home substitutes gain share. Read More. Read More.

Analysts Set New Price Targets

SKIN has been the topic of a number of analyst reports. TD Cowen lifted their price target on Beauty Health from $2.00 to $2.50 and gave the stock a “hold” rating in a research note on Monday, September 22nd. Wall Street Zen lowered shares of Beauty Health from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Cowen reissued a “hold” rating on shares of Beauty Health in a report on Monday, September 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Beauty Health in a research report on Friday, October 31st. Finally, Roth Capital initiated coverage on shares of Beauty Health in a research note on Friday, September 19th. They set a “buy” rating and a $3.50 price objective for the company. One equities research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $2.81.

Beauty Health Price Performance

The company has a market cap of $183.60 million, a PE ratio of -6.55 and a beta of 1.18. The business has a 50 day moving average of $1.41 and a 200 day moving average of $1.74. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01). Beauty Health had a negative return on equity of 19.70% and a negative net margin of 3.87%.The company had revenue of $70.66 million during the quarter, compared to the consensus estimate of $68.33 million. As a group, research analysts predict that The Beauty Health Company will post -0.25 EPS for the current year.

Institutional Trading of Beauty Health

Several large investors have recently bought and sold shares of SKIN. Invesco Ltd. grew its holdings in shares of Beauty Health by 6.6% during the 2nd quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock worth $188,000 after acquiring an additional 6,059 shares during the period. ProShare Advisors LLC grew its stake in Beauty Health by 45.5% in the second quarter. ProShare Advisors LLC now owns 23,447 shares of the company’s stock worth $45,000 after purchasing an additional 7,336 shares during the period. Rhumbline Advisers grew its stake in Beauty Health by 5.7% in the third quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock worth $299,000 after purchasing an additional 8,142 shares during the period. The Manufacturers Life Insurance Company raised its holdings in Beauty Health by 33.5% in the second quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock worth $79,000 after purchasing an additional 10,410 shares in the last quarter. Finally, Public Employees Retirement System of Ohio purchased a new position in Beauty Health during the third quarter valued at $26,000. 93.26% of the stock is owned by institutional investors.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.